TrialGut2002

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.

B R Yacyshyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.